Title : Newer treatments of psoriasis regarding IL-23 inhibitors, phosphodiesterase 4 inhibitors, and Janus kinase inhibitors.

Pub. Date : 2017 Nov

PMID : 28994166






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tofacitinib suppresses the expression of IL-23, IL-17A, IL-17F, and IL-22 receptors during the stimulation of lymphocytes. tofacitinib interleukin 17A Homo sapiens